Latest Starpharma Hldgs ADR (SPHRY) Headlines S
Post# of 12
Posted On: 03/11/2014 10:54:56 AM
Latest Starpharma Hldgs ADR (SPHRY) Headlines
Starpharma Commences Dendrimer-Docetaxel Clinical Trial
Business Wire - Wed Jan 22, 10:49PM CST
Starpharma (ASX:SPL)(OTCQX:SPHRY) today announced that it has received the necessary approvals to commence a phase 1 human clinical trial for its dendrimer-enhanced docetaxel (Taxotere(R)) chemotherapeutic product, referred to as DEP(TM)-Docetaxel.
Starpharma and Makhteshim Agan in Priostar Agrochemical Collaboration
PR Newswire - Wed Mar 13, 3:02AM CDT
Starpharma Holdings Ltd (ASX:SPL; OTCQX: SPHRY) and Makhteshim Agan Group today announced a collaboration program. This will see Starpharma's Priostar® dendrimer technology applied to novel crop protection formulations across Makhteshim Agan's extensive product portfolio.
Starpharma Commences Dendrimer-Docetaxel Clinical Trial
Business Wire - Wed Jan 22, 10:49PM CST
Starpharma (ASX:SPL)(OTCQX:SPHRY) today announced that it has received the necessary approvals to commence a phase 1 human clinical trial for its dendrimer-enhanced docetaxel (Taxotere(R)) chemotherapeutic product, referred to as DEP(TM)-Docetaxel.
Starpharma and Makhteshim Agan in Priostar Agrochemical Collaboration
PR Newswire - Wed Mar 13, 3:02AM CDT
Starpharma Holdings Ltd (ASX:SPL; OTCQX: SPHRY) and Makhteshim Agan Group today announced a collaboration program. This will see Starpharma's Priostar® dendrimer technology applied to novel crop protection formulations across Makhteshim Agan's extensive product portfolio.
(0)
(0)Starpharma Holdings Ltd. (SPHRY) Stock Research Links
Scroll down for more posts ▼